UNSPSC 51184008: Glipalamide

This classification denotes an anti-diabetic agent with the molecular formula C12H15N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) W7J490CUHM, chemically known as 4,5-dihydro-5-methyl-n-((4-methylphenyl)sulfonyl)-1h-pyrazole-1-carboxamide but more generally known as glipalamide, which bears US NIH Compound Identifier 65802. European Medicines Agency schedules Glipalamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07926MIG.

UNSPSC 51184008 Glipalamide is a Commodity code covering a specific pharmaceutical active ingredient used in diabetes management; state and local governments procure this product primarily through public health departments, correctional facilities, and state Medicaid programs for patient care and institutional pharmacy stock. The code encompasses the chemical compound glipalamide itself as a bulk pharmaceutical ingredient or finished dosage form, distinguished from broader diabetes medication categories by its specificity to this single active pharmaceutical ingredient.

The recent-opportunities block contains no posted solicitations under this code, making it difficult to characterize current issuing-body mix, geographic concentration, or representative procurement activity at the state and local level. Without visible recent activity, this code signals either stable existing supplier relationships with infrequent rebidding cycles, procurement handled through state pharmaceutical cooperative agreements or group purchasing organizations, or minimal current demand in the state and local market for this particular medication.